November 25, 2016
4 min watch
Save
This article is more than 5 years old. Information may no longer be current.
VIDEO: Burmester reviews sarilumab trial
WASHINGTON — At the American College of Rheumatology Annual Meeting, Gerd Burmester, MD, professor of medicine and clinical researcher at the Charit University Hospital in Berlin, reviewed the MONARCH trial, a head-to-head study that demonstrated sarilumab was superior to adalimumab.